# Thousands With Heartburn To Get 7-Minute NHS Cancer Test At Local Chemist

> Thousands of people suffering from chronic heartburn could soon be offered a seven-minute sponge on a string test at their local pharmacy to check for cancer.

- Publisher: Briefzora (https://briefzora.com)
- URL: https://briefzora.com/thousands-with-heartburn-to-get-7-minute-nhs-cancer-test-at-local-chemist
- Published: 2026-11-16T14:58:35+05:00
- Author: Briefzora Desk (https://briefzora.com/author/briefzora-desk)
- Section: Health
- Topics: NHS
- Image: https://briefzora.com/uploads/2026/11/thousands-with-chronic-heartburn-condition-to-get-revolutionary-7-minu-i3fai1.webp

## Key points

- Thousands of people with chronic heartburn could receive a 7-minute sponge on a string test at local pharmacies.
- The National Institute for Health and Care Excellence recommended the test for NHS use to check for Barrett's oesophagus.
- The test involves swallowing a capsule containing a sponge that is later pulled out to collect cellular samples.
- Final guidance from Nice is expected in February 2027 following a public consultation ending on December 7.

## Why it matters

Patients suffering from chronic heartburn gain a faster, less invasive screening method for oesophageal cancer risks at local pharmacies, while helping the NHS manage hospital endoscopy capacity.

## Article

Thousands of individuals suffering from chronic heartburn could soon be offered a revolutionary test at their local pharmacy to check for cancer. Known as the sponge on a string test, it takes just seven minutes and can help detect oesophageal cancer early in people with persistent acid reflux. The National Institute for Health and Care Excellence (Nice) today recommended the innovative test for use on the NHS to look for people with Barrett's oesophagus.

Barrett's oesophagus occurs when stomach acid damages the lining of the food pipe and over time, this can cause cells to grow abnormally, which increases the risk of oesophageal cancer. The sponge on a string test can be carried out in general practitioner surgeries, pharmacies and community diagnostic centres and is less invasive than an endoscopy, where a tube carrying a camera is passed down the throat. The test has already been used in a number of pilot schemes, but Nice's recommendation means it could be widely available on the National Health Service in England.

Nice draft guidance recommends two brands of the test, which are Cytosponge and EndoSign, for people with persistent gastro-oesophageal reflux disease, which is commonly known as acid reflux. Barrett's oesophagus is a precursor to oesophageal cancer and it is caused by persistent reflux. The condition affects an estimated 1 to 2 per cent of adults and increases people's risk of oesophageal cancer. Most people with Barrett's oesophagus, however, don't go on to develop the cancer, but the sponge on a string test offers a way to help monitor their condition.

The test doesn't require sedation and works by patients swallowing a small capsule attached to a string, which dissolves in the stomach leaving a small sponge behind. The sponge is then pulled out via the string after a few minutes, collecting cells from the oesophageal lining for analysis in the laboratory. Nice committee members found that patients prefer the sponge on a string test to an endoscopy.

Commenting on the recommendation, Professor Jonathan Benger, chief executive of Nice, said: "Oesophageal cancer is very difficult to treat when it is diagnosed at a later stage, so identifying people sooner is really important." Professor Jonathan Benger added: "Capsule sponge tests offer a quick and less invasive way to detect concerning changes associated with oesophageal cancer or Barrett's oesophagus, helping to identify people who should go on to have further tests and treatment." Professor Jonathan Benger also stated: "This new technology has the potential to make testing easier for patients, while helping the NHS focus valuable endoscopy capacity on those who need it most."

Meanwhile, Professor Peter Johnson, national clinical director for cancer at NHS England, said: "Thousands have already benefited from this incredibly efficient test through pilots we have been running, so it's fantastic it is now being considered for rollout across the country." Nice noted that people who receive an all-clear sponge test result should still be monitored in the long term. And anyone whose results suggest they have Barrett's oesophagus or cancer would still need an endoscopy to further investigate and confirm these findings.

A consultation on Nice draft guidance will now run until December 7 and final guidance can be expected in February 2027. If confirmed, the National Health Service will be required to begin introducing the technology, along with offering specialist staff training, for eligible patients where it is considered the most suitable option. More than 9,000 people are diagnosed with oesophageal cancer in the United Kingdom every year. While it's not clear what causes the cancer, having long-term severe acid reflux or Barrett's oesophagus can increase people's risk. Oesophageal cancer can be hard to spot, but symptoms include having problems swallowing, heartburn or acid reflux and symptoms of indigestion.

## What is Barrett's oesophagus

Barrett's oesophagus is when the lower section of your food pipe or oesophagus is damaged by acid and bile coming back up from your stomach. Over time, the cells of the lining can be replaced by a different type of cell, similar to those that grow in your bowel. This can increase your risk of developing oesophageal cancer, but most people with Barrett's oesophagus don't get cancer. It affects up to two in every 100 people, and is more common in men. You can get it at any age, but most people diagnosed are over 50.

## Causes of Barrett's oesophagus

Barrett's oesophagus is caused by long-term reflux of acid or bile into your food pipe. When acid and bile come back up your oesophagus from your stomach, this is known as gastro-oesophageal reflux disease or acid reflux. Usually, stomach contents are kept in your stomach by a muscular valve. If you have Barrett's oesophagus, this valve may have become weak or moved out of place. Acid and bile from your stomach can then leak upwards.

Over time, the acid and bile from your stomach can cause the cells in the lower part of your oesophagus to become inflamed and damaged. They eventually get replaced by new cells, which are more like the cells that line your stomach. This is your body's way of protecting the lining of your oesophagus from further damage.

## The warning signs of oesophageal cancer

Oesophageal cancer is a cancer of the food pipe. It affects 9,400 people in the United Kingdom every year, and most people are over the age of 60. Smoking increases your risk of the disease, as does being overweight, drinking alcohol and having conditions like Barrett's oesophagus, where the cells lining your oesophagus have become abnormal. Only 12 per cent of patients survive for 10 or more years after being diagnosed. There are around 8,000 oesophageal cancer deaths in the United Kingdom every year, or 22 every day.

Early diagnosis is key, so recognising the symptoms is vital. The most common include difficulty swallowing, unexplained weight loss, indigestion or heartburn that doesn't go away, and pain in the throat or behind the breastbone. But some people also experience a cough, hoarseness, dark poo, tiredness and food coming back up after swallowing.

## Background on National Institute for Health and Care Excellence evaluations

The National Institute for Health and Care Excellence evaluates medical technologies to ensure cost-effectiveness and clinical benefit across healthcare services in England. Draft recommendations undergo rigorous public consultation before final guidance is published for clinical adoption. Medical advisory committees review clinical trial data alongside economic models submitted by manufacturers. The independent evaluation committee assesses whether diagnostic innovations reduce burden on hospital services while improving patient outcomes.

Pilot programmes across various hospital trusts and primary care networks have previously tested the operational delivery of capsule sponge diagnostics. Implementation studies assessed patient tolerance, laboratory processing times, and referral pathways between community pharmacies and secondary care specialists. Health economists measure cost savings achieved by shifting routine surveillance out of hospital endoscopy suites into community settings.

## Oesophageal monitoring and clinical pathways

Patients identified with abnormal cellular changes through primary care testing require structured surveillance programmes to track disease progression over time. Gastroenterology departments manage ongoing care plans for individuals diagnosed with pre-cancerous cellular alterations in the upper gastrointestinal tract. Clinical guidelines dictate frequency of follow-up investigations based on histological findings from initial laboratory analyses.

Gastrointestinal specialists coordinate multidisciplinary teams to deliver timely interventions when dysplasia is detected during routine monitoring. Research initiatives continue to evaluate optimal intervals for repeat sponge procedures among asymptomatic individuals with documented chronic reflux symptoms.

## Frequently asked questions

### What is the sponge on a string test?

It is a 7-minute test where patients swallow a small capsule attached to a string that dissolves to leave a sponge, which collects cells from the oesophageal lining for lab analysis.

### Who is affected by Barrett's oesophagus?

The condition affects an estimated 1 to 2 per cent of adults, is more common in men, and typically occurs in people over the age of 50 who suffer from persistent acid reflux.


---

When citing, please link to https://briefzora.com/thousands-with-heartburn-to-get-7-minute-nhs-cancer-test-at-local-chemist and name Briefzora as the source.
